Skip to content

Earnings yield at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-15.3%-6.8pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-18%-4.7pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
5.3%+4.4pp
Precigen logo
PrecigenPGEN
-14.9%-5.5pp
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-2%-0.9pp
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-9.9%-4.8pp

Other financials

Income statement

See full
Revenue$53.0K-97.3%
Operating income-$14.9M-88.7%
Net income-$15.8M-92.6%
EPS (diluted)-$1.20-62.2%

Balance sheet

See full
Cash & equivalents$206.4M+173%
Total debt$584.0K
Total equity$232.3M+318%
Total assets$263.8M+232%

Cash flow

See full
Operating cash flow-$10.9M-60.5%
CapEx--100%
Free cash flow-$2.7M+72.0%

Valuation

See full
Market cap$1.7B+468%
Enterprise value$1.5B
P/S41.6×

Profitability

See full
Operating margin-183.2%-13.5pp
Net margin71.7%+40.4pp
FCF margin-99.8%-34.2pp

Returns & leverage

See full
Return on equity-34.2%
Debt / equity
Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Palvella Therapeutics's earnings yield?
Palvella Therapeutics (PVLA) reported earnings yield of -2.8% in Q1 2026.
How has Palvella Therapeutics's earnings yield changed year-over-year?
Palvella Therapeutics's earnings yield increased by 62.4% year-over-year, from -7.3% to -2.8%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.